Table 1 Relationship between NOP14 expression levels and clinical features of colorectal cancer patients based on data from TCGA
Characteristic | Low NOP14 expression | High NOP14 expression | p |
|---|---|---|---|
n | 322 | 322 | Â |
Gender, n (%) | Â | Â | 0.527 |
 Female | 155 (24.1%) | 146 (22.7%) |  |
 Male | 167 (25.9%) | 176 (27.3%) |  |
Age, n (%) | Â | Â | 0.032 |
 ≤ 65 | 124 (19.3%) | 152 (23.6%) |  |
 > 65 | 198 (30.7%) | 170 (26.4%) |  |
T stage, n (%) | Â | Â | 0.890 |
 T1 | 10 (1.6%) | 10 (1.6%) |  |
 T2 | 55 (8.6%) | 56 (8.7%) |  |
 T3 | 214 (33.4%) | 222 (34.6%) |  |
 T4 | 40 (6.2%) | 34 (5.3%) |  |
N stage, n (%) | Â | Â | 0.209 |
 N0 | 176 (27.5%) | 192 (30%) |  |
 N1 | 76 (11.9%) | 77 (12%) |  |
 N2 | 68 (10.6%) | 51 (8%) |  |
M stage, n (%) | Â | Â | 0.395 |
 M0 | 235 (41.7%) | 240 (42.6%) |  |
 M1 | 49 (8.7%) | 40 (7.1%) |  |